These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 27477617

  • 1. Comparison of three preclinical models for nausea and vomiting assessment.
    Goineau S, Castagné V.
    J Pharmacol Toxicol Methods; 2016; 82():45-53. PubMed ID: 27477617
    [Abstract] [Full Text] [Related]

  • 2. Automated analysis of delayed emesis in the telemetered ferret: detection of synergistic effects of aprepitant and ondansetron.
    Goineau S, Guillaume P, Barrais L, Castagné V.
    Fundam Clin Pharmacol; 2014 Dec; 28(6):643-51. PubMed ID: 24750138
    [Abstract] [Full Text] [Related]

  • 3. Neuropharmacological mechanisms of emesis. II. Effects of antiemetic drugs on cisplatin-induced pica in rats.
    Takeda N, Hasegawa S, Morita M, Horii A, Uno A, Yamatodani A, Matsunaga T.
    Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):647-52. PubMed ID: 9053584
    [Abstract] [Full Text] [Related]

  • 4. Pica in rats is analogous to emesis: an animal model in emesis research.
    Takeda N, Hasegawa S, Morita M, Matsunaga T.
    Pharmacol Biochem Behav; 1993 Aug; 45(4):817-21. PubMed ID: 8415820
    [Abstract] [Full Text] [Related]

  • 5. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
    Fitzpatrick LR, Lambert RM, Pendley CE, Martin GE, Bostwick JS, Gessner GW, Airey JE, Youssefyeh RD, Pendleton RG, Decktor DL.
    J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
    [Abstract] [Full Text] [Related]

  • 6. The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials.
    Warr DG, Grunberg SM, Gralla RJ, Hesketh PJ, Roila F, Wit Rd, Carides AD, Taylor A, Evans JK, Horgan KJ.
    Eur J Cancer; 2005 Jun; 41(9):1278-85. PubMed ID: 15939263
    [Abstract] [Full Text] [Related]

  • 7. Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis.
    Cocquyt V, Van Belle S, Reinhardt RR, Decramer ML, O'Brien M, Schellens JH, Borms M, Verbeke L, Van Aelst F, De Smet M, Carides AD, Eldridge K, Gertz BJ.
    Eur J Cancer; 2001 May; 37(7):835-42. PubMed ID: 11313170
    [Abstract] [Full Text] [Related]

  • 8. Differential action of domperidone to modify emesis and behaviour induced by apomorphine in the ferret.
    Lau AH, Ngan MP, Rudd JA, Yew DT.
    Eur J Pharmacol; 2005 Jun 15; 516(3):247-52. PubMed ID: 15963978
    [Abstract] [Full Text] [Related]

  • 9. Neuropharmacological mechanisms of emesis. I. Effects of antiemetic drugs on motion- and apomorphine-induced pica in rats.
    Takeda N, Hasegawa S, Morita M, Horii A, Uno A, Yamatodani A, Matsunaga T.
    Methods Find Exp Clin Pharmacol; 1995 Nov 15; 17(9):589-90. PubMed ID: 8786672
    [Abstract] [Full Text] [Related]

  • 10. DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog.
    Yoshida N, Omoya H, Ito T.
    J Pharmacol Exp Ther; 1992 Mar 15; 260(3):1159-65. PubMed ID: 1532032
    [Abstract] [Full Text] [Related]

  • 11. Diphenidol has no actual broad antiemetic activity in dogs and ferrets.
    Nakayama H, Yamakuni H, Nakayama A, Maeda Y, Imazumi K, Matsuo M, Mutoh S.
    J Pharmacol Sci; 2004 Nov 15; 96(3):301-6. PubMed ID: 15528840
    [Abstract] [Full Text] [Related]

  • 12. Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.
    Warneck JB, Cheng FH, Barnes MJ, Mills JS, Montana JG, Naylor RJ, Ngan MP, Wai MK, Daiss JO, Tacke R, Rudd JA.
    Toxicol Appl Pharmacol; 2008 Nov 01; 232(3):369-75. PubMed ID: 18675289
    [Abstract] [Full Text] [Related]

  • 13. Resiniferatoxin antagonizes cisplatin-induced emesis in dogs and ferrets.
    Yamakuni H, Sawai-Nakayama H, Imazumi K, Maeda Y, Matsuo M, Manda T, Mutoh S.
    Eur J Pharmacol; 2002 May 10; 442(3):273-8. PubMed ID: 12065081
    [Abstract] [Full Text] [Related]

  • 14. Strain differences in the development of cisplatin-induced pica behavior in mice.
    Yamamoto K, Yamatodani A.
    J Pharmacol Toxicol Methods; 2018 May 10; 91():66-71. PubMed ID: 29407728
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Scutellaria baicalensis extract decreases cisplatin-induced pica in rats.
    Aung HH, Dey L, Mehendale S, Xie JT, Wu JA, Yuan CS.
    Cancer Chemother Pharmacol; 2003 Dec 10; 52(6):453-8. PubMed ID: 12942313
    [Abstract] [Full Text] [Related]

  • 17. [Aprepitant for the prevention of cisplatine induced nausea and vomiting: an observational study].
    Galy G, Labidi SI, Tissier F, Combes JD, Auger A, Favier B, Latour JF.
    Bull Cancer; 2009 Feb 10; 96(2):141-5. PubMed ID: 19258220
    [Abstract] [Full Text] [Related]

  • 18. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
    Chawla SP, Grunberg SM, Gralla RJ, Hesketh PJ, Rittenberg C, Elmer ME, Schmidt C, Taylor A, Carides AD, Evans JK, Horgan KJ.
    Cancer; 2003 May 01; 97(9):2290-300. PubMed ID: 12712486
    [Abstract] [Full Text] [Related]

  • 19. Action of metyrapone and tetracosactrin to modify cisplatin-induced acute and delayed emesis in the ferret.
    Sam TS, Kan KK, Ngan MP, Rudd JA, Yeung JH.
    Eur J Pharmacol; 2003 Apr 11; 466(1-2):163-8. PubMed ID: 12679153
    [Abstract] [Full Text] [Related]

  • 20. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
    de Wit R, Herrstedt J, Rapoport B, Carides AD, Guoguang-Ma J, Elmer M, Schmidt C, Evans JK, Horgan KJ.
    Eur J Cancer; 2004 Feb 11; 40(3):403-10. PubMed ID: 14746859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.